Last July’s issue marked the first ever GT All-Stars, the best and brightest in the field according to a vote by our readers. (This year’s winners, for whom voting just closed, will be announced in the October issue.)
Of the winners, some have continued making headlines. Craig Venter, selected as most important CEO — who admitted to GT editor Adrienne Burke last year that his genome had been sequenced by Celera — was inducted into the National Academy of Sciences and stepped down from his post at Celera. He also announced the foundation of three nonprofit organizations this April: TIGR Center for the Advancement of Genomics, the Institute for Biological Energy Alternatives, and the J. Craig Venter Science Foundation.
Meanwhile, Elliott Sigal, chosen for big pharma genomics technology, kept climbing the ranks. He was made senior vice president of global clinical and pharmaceutical development at Bristol-Myers Squibb this January and was promoted to senior vice president of drug discovery and exploratory development in March.
Another story in the July 2001 issue looked at a new amplification technique called TempliPhi, developed by John Nelson using Molecular Staging’s rolling circle technology. Their success over the last year earned both Nelson and TempliPhi nominations on this year’s All-Stars ballot. And recently, Molecular Staging announced a paper on another method using multiple displacement amplification.
July’s issue also introduced readers to the home-grown cluster being used for genomics at the American Museum of Natural History. A year later, museum scientists were presenting novel phylogenetic results obtained from studies using the cluster, which has grown to 560 CPUs (see “Museum Conference Says Genomics Advances Illuminate Phylogeny Studies,” pg 32).